Conte M P, Schippa S, Zamboni I, Penta M, Chiarini F, Seganti L, Osborn J, Falconieri P, Borrelli O, Cucchiara S
Paediatric Gastroenterology Unit, University of Rome La Sapienza, Viale Regina Elena 324, Rome 00161, Italy.
Gut. 2006 Dec;55(12):1760-7. doi: 10.1136/gut.2005.078824. Epub 2006 Apr 28.
Clinical and experimental observations in animal models indicate that intestinal commensal bacteria are involved in the initiation and amplification of inflammatory bowel disease (IBD). No paediatric reports are available on intestinal endogenous microflora in IBD.
To investigate and characterise the predominant composition of the mucosa-associated intestinal microflora in colonoscopic biopsy specimens of paediatric patients with newly diagnosed IBD.
Mucosa-associated bacteria were quantified and isolated from biopsy specimens of the ileum, caecum and rectum obtained at colonoscopy in 12 patients with Crohn's disease, 7 with ulcerative colitis, 6 with indeterminate colitis, 10 with lymphonodular hyperplasia of the distal ileum and in 7 controls. Isolation and characterisation were carried out by conventional culture techniques for aerobic and facultative-anaerobic microorganisms, and molecular analysis (16S rRNA-based amplification and real-time polymerase chain reaction assays) for the detection of anaerobic bacterial groups or species.
A higher number of mucosa-associated aerobic and facultative-anaerobic bacteria were found in biopsy specimens of children with IBD than in controls. An overall decrease in some bacterial species or groups belonging to the normal anaerobic intestinal flora was suggested by molecular approaches; in particular, occurrence of Bacteroides vulgatus was low in Crohn's disease, ulcerative colitis and indeterminate colitis specimens.
This is the first paediatric report investigating the intestinal mucosa-associated microflora in patients of the IBD spectrum. These results, although limited by the sample size, allow a better understanding of changes in mucosa-associated bacterial flora in these patients, showing either a predominance of some potentially harmful bacterial groups or a decrease in beneficial bacterial species. These data underline the central role of mucosa-adherent bacteria in IBD.
动物模型中的临床和实验观察表明,肠道共生菌参与了炎症性肠病(IBD)的起始和放大过程。目前尚无关于IBD患儿肠道内源性微生物群的儿科报告。
研究并表征新诊断的IBD患儿结肠镜活检标本中黏膜相关肠道微生物群的主要组成。
对12例克罗恩病患者、7例溃疡性结肠炎患者、6例不确定性结肠炎患者、10例回肠末端淋巴结节增生患者及7例对照者在结肠镜检查时获取的回肠、盲肠和直肠活检标本中的黏膜相关细菌进行定量和分离。通过需氧和兼性厌氧微生物的传统培养技术进行分离和表征,并通过分子分析(基于16S rRNA的扩增和实时聚合酶链反应测定)检测厌氧细菌群或菌种。
IBD患儿的活检标本中发现的黏膜相关需氧和兼性厌氧细菌数量高于对照组。分子方法提示,属于正常肠道厌氧菌群的某些细菌种类或菌群总体减少;特别是,在克罗恩病、溃疡性结肠炎和不确定性结肠炎标本中,普通拟杆菌的出现率较低。
这是首篇研究IBD谱系患者肠道黏膜相关微生物群的儿科报告。尽管这些结果受样本量限制,但有助于更好地了解这些患者黏膜相关细菌菌群的变化,显示出一些潜在有害细菌群占优势或有益细菌种类减少。这些数据强调了黏膜黏附细菌在IBD中的核心作用。